Amgen (AMGN) Tops Q4 EPS by 14c; Guides FY19 Below the Street

Amgen (NASDAQ: AMGN) reported Q4 EPS of $3.42, $0.14 better than the analyst estimate of $3.28. Revenue for the quarter came in at $6.2 billion versus the consensus estimate of $5.87 billion.

GUIDANCE:

Amgen sees FY2019 EPS of $13.10-$14.30, versus the consensus of $14.62. Amgen sees FY2019 revenue of $218-22.9 billion, versus the consensus of $22.94 billion.

For earnings history and earnings-related data on Amgen (AMGN) click here.

You May Also Be Interested In

• Westinghouse said to seek over $50 billion valuation in planned IPO
• Anthropic delays planned IPO from October to November - WSJ
• Lennar Corp. (LEN) Misses Q3 EPS by 10c